Navigation Links
DURECT Corporation Announces Third Quarter 2013 Financial Results and Update of Programs
Date:11/4/2013

, ELADUR®, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR™, SABER®, ORADUR®, TRANSDUR® and ELADUR® are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR, TRANSDUR-Sufentanil, ORADUR-Methylphenidate and Relday are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.

DURECT Forward-Looking Statements The statements in this press release regarding the potential FDA approval or other response to our NDA for POSIDUR, additional clinical trials and potential regulatory submissions for REMOXY, the potential benefits and uses of our drug candidates, clinical trials and product development plans by our collaborators, potential collaborations with third parties and potential business development activities are forward-looking statements involving risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the risk of adverse decisions by regulatory agencies, including requests for additional information or product non-approval of our POSIDUR or other NDA submissions, the risk that Pfizer will discontinue development of REMOXY, delays and additional costs due to requirements imposed by regulatory agencies, potential adverse effects arising from the testing or use of our drug candidates, our potential fai
'/>"/>

SOURCE DURECT Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. DURECT Corporation Invites You to Join its Third Quarter 2013 Earnings Conference Call
2. DURECT Announces Changes to its Board of Directors
3. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
4. DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
5. DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
6. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
7. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
8. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
9. DURECT to Participate in Upcoming Healthcare Conferences
10. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
11. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Echo Therapeutics, Inc. (NASDAQ: ECTE ... recent unauthorized public statements relating to Echo that have ... Shepard M. Goldberg, two members of the Echo Board ... the Echo Board by an affiliate of Platinum Management ... in numerous unauthorized public communications targeted at Echo stockholders, ...
(Date:10/2/2014)... , Oct. 2, 2014 A new Insights ... entitled, " Adherence: why it,s so hard and what ... key research findings on medication adherence and lays out ... percent through new interventions by 2017. For the past ... focused on building the body of scientific knowledge available ...
(Date:10/2/2014)... , Oct. 2, 2014   Softworld, Inc. ... a new practice solely focused on the specific needs ... While Softworld has already been highly successful in ... their additional capabilities to support the quality, regulatory, and ... is now a combination of the current Biometric team ...
Breaking Medicine Technology:Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg 2Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg 3Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg 4CVS Health Insights Report Tackles Complex Issue of Medication Adherence 2CVS Health Insights Report Tackles Complex Issue of Medication Adherence 3Softworld, Inc. Launches Strategic Division Dedicated to Life Sciences Consulting 2
... SAN DIEGO, Jan. 7, 2012  Neurocrine Biosciences, Inc. (Nasdaq: ... its academic founder and member of the Board of ... week.  He was a thoughtful leader with an incredible ... was matched by his terrific wit and disarming good ...
... N.Y., Jan. 6, 2012  VirtualScopics, Inc., (NASDAQ: ... the pharmaceutical, biotechnology and medical device industries, announced today ... from the NASDAQ Stock Market indicating that the Company,s ... consecutive business days.  NASDAQ Marketplace Rule 5550(a)(2)requires a $1.00 ...
Cached Medicine Technology:VirtualScopics Announces Receipt of Notice from Nasdaq 2VirtualScopics Announces Receipt of Notice from Nasdaq 3
(Date:10/2/2014)... PA (PRWEB) October 02, 2014 Social-Engineer, ... social engineering announced today it will host a complimentary ... The webinar will reveal the final outcome of the ... DEF CON 22 in Las Vegas and explore how ... social engineering attacks. To register for the webinar ...
(Date:10/2/2014)... The Business Intelligence Group today ... for Business program. The BIG Awards specialize in ... judging process scored by well-known and experienced leaders ... winners this year epitomize what is going right ... the Business Intelligence Group. “The sheer amount of ...
(Date:10/2/2014)... BamboofloorChina.com is a distinguished bamboo product ... great appreciation from the global customers in the past ... make more excellent items. All its online workers are ... clients. , The company has recently added a ... website. Furthermore, the company’s marketing specialist has announced that ...
(Date:10/2/2014)... Maureen Salamon ... News) -- Middle-aged women with a neurotic personality style ... developing Alzheimer,s disease, new research suggests. Tracking 800 ... those who were most anxious, jealous and moody -- ... stress had double the risk of developing Alzheimer,s compared ...
(Date:10/2/2014)... may interact with stress to trigger heart disease in some ... in about 13 percent of people, but only in those ... their heart disease risk through simple measures such as ... researchers said. The study authors analyzed genetic data from ... in the EBF1 gene and higher levels of central obesity, ...
Breaking Medicine News(10 mins):Health News:Social-Engineer, Inc. Announces DEF CON 22 Capture the Flag Results in a Complimentary Webinar 2Health News:Social-Engineer, Inc. Announces DEF CON 22 Capture the Flag Results in a Complimentary Webinar 3Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2
... The Vatican has yet again been forced to revise ... a foreign trip. En route to Cameroon on March 17, ... of HIV. A transcript of the pope,s comments on the ... "risked" aggravating the problem.Jon O,Brien, president of Catholics for Choice, ...
... found levels of certain cytokines spiked during disease stage ... South Africa recently had the rare opportunity to follow ... and recovery in a 29-year-old lab worker who had ... particular, the researchers followed the trajectory of cytokines, a ...
... hypertension, obesity, study found , , WEDNESDAY, March 18 (HealthDay News) ... than whites, a long-running study shows. , "What we found ... and it is not a rare occurrence," said Dr. Kirsten ... issue of the New England Journal of Medicine . ...
... the care needs of a child dependent on technology is ... upon mothers to help everyone in the family adjust. However, ... the challenges of raising these children, a research study from ... its cues from me," one mother told Valerie Toly, PhD, ...
... clinicians to identify study participants could compromise the recruitment ... to address this conflict of interest in their Institutional ... associate professor of law at Georgia State University, studied ... 117 medical schools that received National Institutes of Health ...
... March 18 Cogdell Spencer Inc. (NYSE: ... has declared a quarterly dividend of $0.225 per common share ... March 31, 2009. The dividend covers the first quarter ... Cogdell Spencer Inc. (NYSE: CSA ) is a ...
Cached Medicine News:Health News:Pope Not Infallible on Condoms 2Health News:Course of West Nile Infection Charted 2Health News:Course of West Nile Infection Charted 3Health News:High Rate of Early Heart Failure Seen in Blacks 2Health News:High Rate of Early Heart Failure Seen in Blacks 3Health News:Mothers have key role in family life for children with technology dependencies 2Health News:Conflicts of interest in clinical research 2Health News:Cogdell Spencer Inc. Declares Quarterly Dividend 2
Large. 2.5 mm diameter blade. Angled up 45 degrees. Round handle....
3 mm curved blade. Round handle....
9 mm blade....
Storz Ear Knife Handle....
Medicine Products: